{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:39:18Z","timestamp":1793126358007,"version":"4.5.0"},"reference-count":83,"publisher":"Informa UK Limited","issue":"10","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"name":"UK Biological and Biosciences Research Council","award":["BB\/Y003268\/1"],"award-info":[{"award-number":["BB\/Y003268\/1"]}]},{"name":"Breast Cancer Now","award":["KCL-Q4-Y1"],"award-info":[{"award-number":["KCL-Q4-Y1"]}],"id":[{"id":"https:\/\/ror.org\/02qa92s63","id-type":"ROR","asserted-by":"crossref"}]},{"name":"King\u2019s Health Partners Centre for Translational Medicine","id":[{"id":"https:\/\/ror.org\/05qk4xh70","id-type":"ROR","asserted-by":"crossref"}]},{"name":"King\u2019s Health Partners"},{"name":"University of Strathclyde","id":[{"id":"https:\/\/ror.org\/00n3w3b69","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Delivery"],"published-print":{"date-parts":[[2026,10,3]]},"DOI":"10.1080\/17425247.2026.2713673","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T11:42:43Z","timestamp":1785757363000},"page":"1761-1774","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Developing next-generation antibody-drug conjugates for breast cancer drug delivery: hurdles and advances in the clinic"],"prefix":"10.1080","volume":"23","author":[{"given":"Callum","family":"Chapman","sequence":"first","affiliation":[{"name":"University of Strathclyde","place":["Glasgow, UK"]},{"name":"AstraZeneca","place":["Durham, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Cheung","sequence":"additional","affiliation":[{"name":"King\u2019s College London","place":["London, UK"]},{"name":"Guy\u2019s Cancer Centre","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina B.","family":"Armstrong","sequence":"additional","affiliation":[{"name":"University of Strathclyde","place":["Glasgow, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia N.","family":"Karagiannis","sequence":"additional","affiliation":[{"name":"King\u2019s College London","place":["London, UK"]},{"name":"Guy\u2019s Cancer Centre","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Rattray","sequence":"additional","affiliation":[{"name":"University of Strathclyde","place":["Glasgow, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(25)00730-2"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2025.115648"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00039.2025"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1814017"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00725-0"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2028485"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2026.03.008"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12030670"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2022.2042252"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(25)00470-X"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.62347\/EMIK7909"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15041130"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-026-00904-5"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.3892\/BR.2024.1900"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.JSBMB.2024.106639"},{"key":"e_1_3_5_18_1","unstructured":"Bristol Myers Squibb. SystImmune and Bristol Myers Squibb highlight positive phase III interim topline results for izalontamab brengitecan (Iza-bren) in previously treated unresectable locally advanced or metastatic triple-negative breast cancer [Internet]. 2026. Available from: https:\/\/news.bms.com\/news\/corporate-financial\/2026\/SystImmune-and-Bristol-Myers-Squibb-Highlight-Positive-Phase-III-Interim-Topline-Results-for-izalontamab-brengitecan-Iza-bren-in-Previously-Treated-Unresectable-Locally-Advanced-or-Metastatic-Triple-Negative-Breast-Cancer\/default.aspx"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-23-3110"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.TARG-25-A127"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-025-01011-7"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2025-344"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.36401\/JIPO-24-34"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2025.104872"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1158\/2767-9764.CRC-23-0284"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-24-0444"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1158\/2767-9764.CRC-24-0248"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-22-0099"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-51453-w"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-025-00751-w"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2407086"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-026-01150-1"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-020-00995-2"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70274"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-13-0926"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-1313"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.9651"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-0652"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2017.08.015"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.16_suppl.3023"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-025-00869-w"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02489-2"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2016.268"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1914510"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.c18-00744"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2022.2286"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2022.100554"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature17038"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a031252"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.00775"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-1564"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2021.39.15_suppl.LBA4"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-019-0028-1"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1038\/d41573-024-00001-x"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2025.102940"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-002194"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.2c01791"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1021\/acschembio.0c00285"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41570-025-00784-6"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-024-07439-0"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-22-0837"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.01909"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01245-X"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-025-00829-5"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-025-00743-w"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-023-00849-9"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-16-0364"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-16-0658"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-024-01279-8"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00159-1"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2022-5284"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-23-4099"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01287"},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021239"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-61779-931-0_15"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2024.2436094"},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13030430"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-014-9710-8"},{"key":"e_1_3_5_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ddtec.2018.10.003"},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-018-0235-2"},{"key":"e_1_3_5_81_1","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2022.2115205"},{"key":"e_1_3_5_82_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-25-0874"},{"key":"e_1_3_5_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2025.11.005"},{"key":"e_1_3_5_84_1","unstructured":"National Cancer Institute. Treatment of ADC-Refractory breast CancEr with dato-DXd or T-DXd: TRADE DXd (TRADE DXd) [Internet]. Report No.: nCT06533826. [cited 2026 Apr 28]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06533826"},{"key":"e_1_3_5_85_1","unstructured":"National Cancer Institute. Personalized antibody-drug conjugate therapy based on RNA and protein testing for the treatment of advanced or metastatic solid tumors (the ADC MATCH screening and treatment trial) [Internet]. Report No.: nCT06311214. [cited 2026 Apr 28]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06311214"}],"container-title":["Expert Opinion on Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17425247.2026.2713673","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/17425247.2026.2713673","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17425247.2026.2713673","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:06:50Z","timestamp":1790870810000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17425247.2026.2713673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":83,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10,3]]}},"alternative-id":["10.1080\/17425247.2026.2713673"],"URL":"https:\/\/doi.org\/10.1080\/17425247.2026.2713673","relation":{},"ISSN":["1742-5247","1744-7593"],"issn-type":[{"value":"1742-5247","type":"print"},{"value":"1744-7593","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iedd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iedd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-05-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}